Abstract
miR-4429 acts as an inhibitor in many malignant tumors and participates in the biological processes of them, but the clinical value and potential molecular mechanism of miR-4429 in cervical cancer (CC) are still under investigation. To analyze the clinical value and molecular mechanism of miR-4429 in CC. A qRT-PCR assay was employed to determine the levels of miR-4429 and forkhead-box M1 (FOXM1) in CC tissues, CC cell lines (SiHa, CaSki, ME-180, and C33A) and human normal immortalized epithelial cell lines (HaCaT). The proliferation, migration, invasion, and apoptosis abilities of ME-180 and C33A cells were detected, and the epithelial-to-mesenchymal transition (EMT)-related proteins in the cells were also determined. MiR-4429 acted as a tumor suppressor gene in CC tissues and cells and was linked to lymph node metastasis and International Federation of Gynecology and Obstetrics (FIGO) staging. The survival analysis revealed that lymph node metastasis, high FIGO staging, and low miR-4429 expression were all related to the unfavorable prognosis of the patients, and the dual-luciferase reporter assay revealed that FOXM1 was the target of miR-4429. Both overexpression of miR-4429 and knock-down of FOXM1 inhibited the proliferation...Continue Reading
References
Sep 27, 2012·FEBS Letters·Jipeng LiWanjun Yu
Jul 30, 2014·FEBS Letters·Xu-Ri LiShu-Zhen Dai
Dec 3, 2014·Biochemical and Biophysical Research Communications·Lu-Ying WanJian-Ping Xiong
Nov 18, 2015·Cancer Biology & Therapy·Jun ZhangZhongqiu Lin
Nov 21, 2015·Oncotarget·Xiaohui TanSidney W Fu
Mar 16, 2016·BMC Cancer·Oscar Peralta-ZaragozaCarlos Pérez-Plasencia
Jan 6, 2017·Cell Death & Disease·Meng-Na ZhanQian Zhao
Sep 1, 2017·Seminars in Cancer Biology·Deeptashree NandiAlo Nag
Oct 13, 2017·Cell Biochemistry and Function·Karthik Subramanian ChandrasekaranDevarajan Karunagaran
Dec 22, 2017·Cancer Medicine·Xiaoxiao XuShenglan Ye
Feb 2, 2018·Experimental and Therapeutic Medicine·Pingping TaoQing Li
Mar 1, 2018·Pathology, Research and Practice·Yue ZhuYungui Cao
Mar 24, 2018·World Journal of Gastroenterology : WJG·Cheng ZhangDong-Qiu Dai
Apr 29, 2018·European Journal of Pharmacology·Guanghong XiuZe Zhang
May 1, 2018·Biochemical and Biophysical Research Communications·Na ChaiRui Zhang
May 12, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Recep BayraktarBulent Ozpolat
May 20, 2018·Scientific Reports·Ravindresh Chhabra
Jun 17, 2018·Scientific Reports·Ádám NagyBalázs Győrffy
Aug 28, 2018·Cancer Management and Research·Yunxia LiShuyun Li
Nov 9, 2018·Biochemical and Biophysical Research Communications·Wei SongLei Chen
Jan 11, 2019·Molecular Medicine Reports·Yawei LiFang Su
Feb 19, 2019·Cancer Management and Research·Wenwen WeiXiulan Shi
Mar 8, 2019·Cancer Biotherapy & Radiopharmaceuticals·Hong PanXiaojian Zhang
Apr 4, 2019·Molecular Cancer·Mengyue ZhengYan Lu
Jun 14, 2019·Journal of Cellular Physiology·Hongbo SunLin Wu
Aug 10, 2019·Biochemical and Biophysical Research Communications·Huabo HeLixin Chai
Nov 13, 2019·Bioscience Reports·Xiaolei LiuLijun Liu
Feb 6, 2020·Cold Spring Harbor Perspectives in Biology·Joseph Lipsick